Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
- 试验地点
- 2
- 主要终点
- Number of Patients' Rheumatologists Using SLE@Duke
研究概览
简要总结
The purpose of this study is to pilot test SLE@Duke, a set of tools to implement the Type 1 & 2 SLE Model in a clinical setting, as well as to gain an in-depth understanding of providers experiences using the intervention during clinic visits with patients with systemic lupus erythematosus.
This record represents Aim 3 of this study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All providers in Duke Rheumatology who practice outside of the Duke Lupus Clinic are eligible.
- •Patients are eligible to participate if they have an established diagnosis of SLE and are followed in Duke Rheumatology.
- •All patients with a SLE diagnosis will be included in the analysis. SLE diagnosis will be based on an ICD-10 code for SLE (M32.1*, M32.8, M32.9) in the EMR.
排除标准
- •New patients will be excluded
结局指标
主要结局
Number of Patients' Rheumatologists Using SLE@Duke
时间窗: Baseline (month 1), intervention period (month 2)
Collected from EMR (electronic medical record). This is a composite measure that includes documentation in the clinic note of any component of SLE@Duke: (1) Type 1 \& 2 SLE Model mentioned, (2) dotphrase used, (3) Type 1 \& Type 2 PGAs (Physician Global Assessments) scored in note, (4) handout mentioned, (5) Type 2 symptoms discussed, or (6) purple sheet documented.
Length of Clinic Visits
时间窗: Baseline (month 1), intervention period (month 2)
Collected from EMR (electronic medical record).
Perceived Benefits of SLE@Duke, as Measured by Provider Interviews
时间窗: 4 weeks
In-depth interviews with participating rheumatologists related to the intervention, including acceptability, utility, implementation, integration and practicality of SLE@Duke.
How SLE@Duke Fit Into Work Flow, as Measured by Provider Interviews
时间窗: 4 weeks
In-depth interviews with participating rheumatologists related to the intervention, including acceptability, utility, implementation, integration and practicality of SLE@Duke.
Change in Physician Satisfaction With Visits With Lupus Patients, as Measured by Provider Survey
时间窗: Baseline (month 1), intervention period (month 2)
Satisfaction was measured on a scale of 1-5, where 1 = never and 5 = always in response to the statement: "After seeing a patient with lupus, I leave the exam room feeling satisfied with the encounter."
Perceived Barriers of SLE@Duke, as Measured by Provider Interviews
时间窗: 4 weeks
In-depth interviews with participating rheumatologists related to the intervention, including acceptability, utility, implementation, integration and practicality of SLE@Duke.
Change in Acceptability of SLE@Duke, as Measured by Provider Survey
时间窗: Baseline (month 1), intervention period (month 2)
Questions pertaining to acceptability of SLE@Duke were measured on a scale of 1-5, where 1 = completely disagree and 5 = completely agree.
Change in Appropriateness of SLE@Duke, as Measured by Provider Survey
时间窗: Baseline (month 1), intervention period (month 2)
Questions pertaining to the appropriateness of SLE@Duke were measured on a scale of 1-5, where 1 = completely disagree and 5 = completely agree.
Change in Feasibility of SLE@Duke, as Measured by Provider Survey
时间窗: Baseline (month 1), intervention period (month 2)
Questions concerning feasibility of SLE@Duke were measured on a scale of 1-5, where 1 = completely disagree and 5 = completely agree.
Number of Lupus Patients With Assessment of Type 1 and 2 SLE in Note
时间窗: Baseline (month 1), intervention period (month 2)
Collected from EMR (electronic medical record).
Number of Lupus Patients With Type 2 SLE Treatment in Note
时间窗: Baseline (month 1), intervention period (month 2)
Collected from EMR (electronic medical record).
Number of Lupus Patients With PRO (Patient-reported Outcomes) in Note
时间窗: Intervention period (month 2), month 5
Collected from EMR (electronic medical record).
Difference in Understanding of Lupus Activity & Treatment Plan, as Measured by Patient Survey
时间窗: Baseline (month 1), intervention period (month 2)
Questions pertaining to understanding were measured on a scale of 1-5, where 1 = strongly disagree and 5 = strongly agree. Different patients completed the survey at month 1 and month 2. The scores at month 1 were averaged, then subtracted from the average score at month 2.
Difference in Perceived Quality of Visit, as Measured by Patient Survey
时间窗: Baseline (month 1), intervention period (month 2)
Each question pertaining to quality of visit was measured on a scale of 1-5, where 1 = strongly disagree and 5 = strongly agree. Different patients completed the survey at month 1 and month 2. The scores at month 1 were averaged, then subtracted from the average score at month 2.
Discussion of the Type 1 and 2 Model, as Measured by Patient Survey
时间窗: Intervention period (month 2)
The patient survey asked patients to respond "Yes" or "No" in response to the statement: "My rheumatologist discussed Type 1 \& Type 2 lupus with me today."
Change in Discussion of the Type 1 and 2 Model, as Measured by Provider Survey
时间窗: Baseline (month 1), intervention period (month 2)
Discussion of the Type 1 \& 2 SLE Model was measured on a scale of 1-5, where 1 = "never" and 5 = "always" in response to the statement: "I discuss the Type 1 \& 2 SLE Model with the patient."
次要结局
未报告次要终点